Villaren, Reighven James S.

HRN: 23-34-96  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/01/2024
CEFUROXIME 750MG (VIAL)
11/01/2024
11/08/2024
IV
300mg
Q8H
PCAP B
Waiting Final Action 
11/02/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
11/02/2024
11/09/2024
PO
3.6ml
Q8h
Age
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: